… using synergistic combinations of different therapeutic agents… for GBM treatment, the rationales
of drug combinations with … perspectives of nanocarrier-based combination therapies. The …

… nanocarrier-based drug delivery for treatment of GBMs, which may be a promising therapeutic
… The new development of nanocarrier-based combination therapy for GBMs has additional …

… drugs in blood and at the tumor site. So, this article delivers a brief review of using various
lipid-based nanocarriers loaded with drug combinations against GBM. … Combination therapy is …

… carried out on U87 malignant glioma cells, the IC50 values of drug solution and developed …
higher for the combination therapy compared to from drug solution. Thus it indicated that the …

… significant change neither in the mortality rate of brain cancer cases nor to improve the
quality of life of patients. Nanocarrier-based drug delivery systems though have brought a ray of …

… Glioblastoma multiforme (GBM), a type of glioma, is the most frequently occurring and …
GBM is defined by the World Health Organization (WHO) as grade IV, the most malignant glioma …

… The combination of irinotecan with other medications such as TMZ and bevacizumab has
demonstrated promising results for treating GBM. These combination treatments showed …

… explored for GBM drug delivery, as they support both passive and active drug targeting
by crossing/… Although these nanocarriers could be a plausible choice for treating GBM, in-depth …

… Treatment strategies for glioblastoma are comprised of surgical resection, radiation therapy,
and chemotherapy along with combination therapy. … for managing the glioblastoma patients […

… NANOCARRIER-BASED APPROACHES … of novel nanocarrier-based combination therapy
for GBM include synergistic effects of drugs, improved targeting of anticancer drugs inside the …